SBI Securities’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.84K Buy
1,591
+5
+0.3% +$27 ﹤0.01% 1957
2026
Q1
$8.56K Buy
1,586
+11
+0.7% +$66 ﹤0.01% 1795
2025
Q4
$10.9K Buy
1,575
+5
+0.3% +$33 ﹤0.01% 1693
2025
Q3
$10.1K Sell
1,570
-3,550
-69% -$24.3K ﹤0.01% 1772
2025
Q2
$34.1K Buy
5,120
+890
+21% +$4.57K ﹤0.01% 1207
2025
Q1
$27.4K Buy
4,230
+3,001
+244% +$21.6K ﹤0.01% 1213
2024
Q4
$9.91K Buy
+1,229
New +$10.1K ﹤0.01% 1652

Other funds holding BHC

SBI Securities's BHC Position: Q2 2026 in Review

SBI Securities increased its Bausch Health (BHC) stake by 0.32% in Q2 2026, buying an estimated $27 and bringing the position to 1,591 shares worth $7.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1957.

SBI Securities first reported a position in BHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $34.1K in Q2 2025. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • SBI Securities held 1,591 shares of Bausch Health worth $7.84K as of Q2 2026.
  • SBI Securities bought 5 Bausch Health shares in Q2 2026, an estimated $27.
  • Bausch Health made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1957 holding.
  • SBI Securities first reported a position in Bausch Health in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Bausch Health position peaked at $34.1K in Q2 2025.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.